NEW PERSPECTIVES OF DIPYRIDAMOL USAGE IN TREATMENT OF CORONARY HEART DISEASE

• Main Authors: Y. I. Buziashvili, S. T. Matskeplishvili, E. U. Asymbekova, I. H. Hapiy, T. V. Burduli, O. S. Sherbakova, V. I. Buvaltsev
• Format: Article
• Language: Russian
• Published: «FIRMA «SILICEA» LLC 2003-08-01
• Series: Российский кардиологический журнал
• Subjects: coronary heart disease (chd); angiogenesis; stress echo; dipyridamol
• Online Access: https://russjcardiol.elpub.ru/jour/article/view/1774
• ISSN: 1560-4071; 2618-7620

There is a great number of coronary patients to whom traditional methods of myocardium revascularization are not indicated. Addition of dipyridamol to traditional antianginal treatment promotes improvement of clinical features of the disease and decreased functional class of angina in coronary patients. The usage of dipyridamol for 3 months was accompanied by increased physical stress tolerance threshold, increased time of physical stress, decreased asynergy areas on echo ate peak stress, suggesting possible angiogenesis in myocardium hypoperfusion areas in the region of stenotic coronary artery.